ArticleJournal of neuro-oncology2026

Diffusion histogram analysis predicts progression-free survival in contrast enhancing recurrent IDH mutant gliomas treated with bevacizumab.

Elizabeth Loxterkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.